Related Experiment Video
Updated: Aug 3, 2026
14:25
Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time
Published on: May 20, 2014
Angiogenesis in ovarian cancer
M R Brown1, J O Blanchette, E C Kohn
1Molecular Signaling Section, Laboratory of Pathology, National Cancer Institute, Bethesda, MD 20892, USA.
Summary
New blood vessel formation (angiogenesis) fuels ovarian cancer spread and ascites. Targeting angiogenesis offers promising therapeutic strategies for ovarian cancer patients.
Area of Science:
- Oncology
- Vascular Biology
Background:
- Angiogenesis, the formation of new blood vessels, is crucial for ovarian cancer progression, including metastasis and ascites.
- Growth factors driving ovarian cancer invasion are also key players in tumor angiogenesis.
- Cancer cells disrupt the balance of pro-angiogenic and anti-angiogenic factors, leading to abnormal vascularization and leakage.
Purpose of the Study:
- To explore the role of angiogenesis in ovarian cancer development and metastasis.
- To investigate the prognostic significance of angiogenic factors and tumor-associated microvessels in ovarian cancer.
- To highlight the therapeutic potential of targeting angiogenesis in ovarian cancer treatment.
Main Methods:
- Review of literature on angiogenesis in ovarian cancer.
- Analysis of the role of pro-angiogenic factors and their imbalance.
- Examination of microvessel density as a prognostic marker.
Main Results:
- Angiogenesis is intrinsically linked to ovarian cancer invasion, ascites, and metastasis.
- Elevated pro-angiogenic factors and increased tumor microvessels correlate with poor patient outcomes.
- These angiogenic markers may also reflect tumor burden and ascites formation.
Conclusions:
- Understanding the molecular and cellular mechanisms of angiogenesis in ovarian cancer is vital.
- Targeting angiogenesis represents a key therapeutic strategy for ovarian cancer.
- Further research can improve patient outcome prediction and treatment efficacy.
Related Concept Videos
02:07Oogenesis
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
01:10Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...